MedTrace Logo

Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?

NCT00259168 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2018-12-03

No results posted yet for this study

Summary

The purpose of this study is to determine whether attenuation/normalization of elevated blood sugar after meals ameliorates vessel wall (endothelial) function in individuals with insulin resistance.

Conditions

Interventions

DRUG

Nateglinide

Sponsors & Collaborators

  • Novartis

    collaborator INDUSTRY

  • Bayer

    collaborator INDUSTRY

  • Atheline Major-Pedersen

    lead OTHER

Principal Investigators

  • Christian Torp-Pedersen, MD, DMSc · Bispebjerg Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30
Primary Completion
2006-03-31
Completion
2006-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00259168 on ClinicalTrials.gov